DE69132040D1 - Wachstumsfaktor II für vaskuläre Endothelzellen - Google Patents

Wachstumsfaktor II für vaskuläre Endothelzellen

Info

Publication number
DE69132040D1
DE69132040D1 DE69132040T DE69132040T DE69132040D1 DE 69132040 D1 DE69132040 D1 DE 69132040D1 DE 69132040 T DE69132040 T DE 69132040T DE 69132040 T DE69132040 T DE 69132040T DE 69132040 D1 DE69132040 D1 DE 69132040D1
Authority
DE
Germany
Prior art keywords
growth factor
endothelial cells
vascular endothelial
vascular
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132040T
Other languages
English (en)
Other versions
DE69132040T2 (de
Inventor
Marvin L Bayne
Gregory L Conn
Thomas, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69132040D1 publication Critical patent/DE69132040D1/de
Publication of DE69132040T2 publication Critical patent/DE69132040T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69132040T 1990-09-21 1991-09-18 Wachstumsfaktor II für vaskuläre Endothelzellen Expired - Fee Related DE69132040T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58663890A 1990-09-21 1990-09-21
US58664090A 1990-09-21 1990-09-21

Publications (2)

Publication Number Publication Date
DE69132040D1 true DE69132040D1 (de) 2000-04-20
DE69132040T2 DE69132040T2 (de) 2000-11-02

Family

ID=27079771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132040T Expired - Fee Related DE69132040T2 (de) 1990-09-21 1991-09-18 Wachstumsfaktor II für vaskuläre Endothelzellen

Country Status (4)

Country Link
EP (1) EP0476983B1 (de)
JP (1) JP2656406B2 (de)
CA (1) CA2051796A1 (de)
DE (1) DE69132040T2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0506477B1 (de) 1991-03-28 1999-06-23 Merck & Co. Inc. Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
CA2125763C (en) * 1993-07-02 2007-08-28 Maurice Kent Gately P40 homodimer of interleukin-12
US6734285B2 (en) 1994-03-08 2004-05-11 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 proteins and compositions
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US5932540A (en) * 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
AU696764B2 (en) * 1994-03-08 1998-09-17 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US6040157A (en) 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US5820725A (en) * 1995-08-11 1998-10-13 Lintec Corporation Tape application device
IL131021A0 (en) 1997-01-29 2001-01-28 Cornell Res Foundation Inc Multiple site delivery of adenoviral vector for the induction of angiogenesis
US6486133B1 (en) 1997-03-07 2002-11-26 The Wistar Institute Of Anatomy And Biology Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
US6796351B1 (en) 1997-11-17 2004-09-28 Lintec Corporation Tape application device
JP3459345B2 (ja) * 1997-11-17 2003-10-20 リンテック株式会社 テープ貼付装置
US7722671B1 (en) 1998-01-27 2010-05-25 St. Jude Medical, Inc. Medical devices with associated growth factors
US6375680B1 (en) 1998-12-01 2002-04-23 St. Jude Medical, Inc. Substrates for forming synthetic tissues
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6726718B1 (en) 1999-12-13 2004-04-27 St. Jude Medical, Inc. Medical articles prepared for cell adhesion
EP1313512A4 (de) 2000-08-04 2004-08-25 Human Genome Sciences Inc Vaskulärer endothel-wachstumsfaktor 2(15.02.02)
JP4467172B2 (ja) 2000-11-30 2010-05-26 リンテック株式会社 テープ貼付装置
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
JP2004536579A (ja) 2001-04-13 2004-12-09 ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド 血管内皮増殖因子２
US7402312B2 (en) 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
JP2005515157A (ja) * 2001-05-25 2005-05-26 トマス ジェファソン ユニバーシティ 多様な治療様式のための主成分としての選択的スプライスフォーム
US7217570B2 (en) 2001-08-23 2007-05-15 The Wistar Institute Of Anatomy And Biology Organotypic intestinal culture and methods of use thereof
US7371258B2 (en) 2001-10-26 2008-05-13 St. Jude Medical, Inc. Valved prosthesis with porous substrate
US7696320B2 (en) 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
US8033004B2 (en) 2004-11-22 2011-10-11 Honda Motor Co., Ltd. Method for installing run channel for automobile
JP4376173B2 (ja) 2004-11-30 2009-12-02 本田技研工業株式会社 モール装着方法及びその装置
FI20041572A (fi) 2004-12-03 2006-06-04 Biolan Oy Kasvihuone, kasvihuoneen ilmastonsäätöjärjestelmä ja menetelmä kasvihuoneen ilmaston säätämiseksi
EP2314614B1 (de) 2005-02-28 2015-11-25 Sangamo BioSciences, Inc. Anti-angiogene Verfahren und Zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437281B1 (de) * 1984-12-24 1994-04-13 Merck & Co. Inc. Zubereitung enthaltend ein saures Fibroblastewachstumfaktor (aFGF)
CA2017379C (en) * 1989-05-24 2002-06-25 Kenneth A. Thomas, Jr. Purification and characterization of a glioma-derived growth factor

Also Published As

Publication number Publication date
EP0476983B1 (de) 2000-03-15
CA2051796A1 (en) 1992-03-22
DE69132040T2 (de) 2000-11-02
EP0476983A1 (de) 1992-03-25
JP2656406B2 (ja) 1997-09-24
JPH0565298A (ja) 1993-03-19

Similar Documents

Publication Publication Date Title
DE69132040D1 (de) Wachstumsfaktor II für vaskuläre Endothelzellen
DE69229454D1 (de) Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
DE69024351D1 (de) In längsrichtung nachgiebiges gefässtransplantat
DE68913152D1 (de) Kunstknochenstruktur für knochentransplantation.
DE69123825D1 (de) Artikel für das rauchen
DE69122369D1 (de) Dreilagige Gefässprothese
DOP1988004632A (es) Mejora en implantes antimicrobianos recubiertos
DE69326847D1 (de) Tragärmezusammensetzung für regale
DE69127467D1 (de) Preistragende behältereinheiten
DE69636114D1 (de) Endovaskuläres aortisches transplantat
DK0474015T3 (da) Endoprotese
DK433485D0 (da) Vaeksthormonfrigivende faktor
DK108685A (da) Vaekstfaktor i
DK29684D0 (da) Vasculaer protese
DE69119404D1 (de) Stütze für topfpflanzen
EP0550296A3 (en) Vascular endothelial cells growth factor
DE69127527D1 (de) Speicheranordnung
NO884943L (no) Cellevekstinhiberende faktor.
DK354389A (da) Neutrofilaktiverende faktor
DE69309555D1 (de) Träger für Schwimmflossen
DE69116161D1 (de) Trägerrinne für gewächshäuser
ID19230A (id) Pengatur pertumbuhan tanaman dalam zat pelarut pirrolidon
IL96902A0 (en) T cell growth factor
DK602188D0 (da) Hybridomdyrkningsmedium
FI934188A (fi) Plant slitsantenn naetverk

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee